|
End-of-day quote
Taiwan S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 55.90 TWD | -0.18% |
|
-0.53% | +4.40% |
| Market Cap | 9.99B 314M 272M 257M 233M 437M 30.11B 440M 3.07B 1.18B 15.27B 1.18B 1.15B 48.56B | P/E 2024 |
12.6x | P/E 2025 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 8.55B 269M 233M 220M 200M 374M 25.78B 377M 2.63B 1.01B 13.08B 1.01B 988M 41.58B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.29x |
| Free-Float |
44.21% | Yield 2024 |
4.52% | Yield 2025 | 3.4% |
| 1 day | -0.18% | ||
| 1 week | -0.53% | ||
| Current month | -1.41% | ||
| 3 months | -1.62% | ||
| 6 months | -2.24% | ||
| Current year | +4.40% |
| 1 week | 55.7 |  | 56.4 |
| 1 month | 55.7 | | 57.5 |
| Current year | 53.55 | | 60.55 |
| 1 year | 48.64 | | 60.55 |
| 3 years | 46.55 | | 72.18 |
| 5 years | 33.55 | | 72.36 |
| 10 years | 24.86 | | 72.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zi Ting Fan
CEO | Chief Executive Officer | - | 2006-05-29 |
Reynold Hsu
DFI | Director of Finance/CFO | - | 2019-07-15 |
Shu Hua Chen
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Tsui Wen Yeh
BRD | Director/Board Member | - | 2002-05-28 |
Zi Ting Fan
CHM | Chairman | - | - |
Yuan Te Li
BRD | Director/Board Member | - | 2012-06-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -0.53% | +9.41% | -8.22% | 314M | |
| +2.02% | -0.96% | +50.69% | +92.40% | 1,015B | |
| +0.28% | -3.24% | +49.57% | +62.65% | 642B | |
| +1.81% | +2.07% | +19.89% | +70.38% | 463B | |
| -1.01% | +2.20% | +37.56% | +37.06% | 353B | |
| -0.12% | +1.88% | +16.63% | +23.46% | 265B | |
| -0.90% | +1.45% | +5.55% | +10.13% | 254B | |
| +1.10% | -12.75% | +38.03% | +45.44% | 206B | |
| -0.47% | -4.38% | -21.37% | -58.11% | 191B | |
| +1.87% | -3.04% | +27.81% | +89.26% | 182B | |
| Average | +0.24% | -3.04% | +23.38% | +36.44% | 357.05B | |
| Weighted average by Cap. | +0.52% | -2.21% | +33.70% | +56.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.79B 214M 185M 175M 158M 297M 20.46B 299M 2.09B 803M 10.38B 802M 784M 33B | 7.02B 221M 191M 181M 164M 307M 21.17B 310M 2.16B 831M 10.74B 830M 811M 34.14B |
| Net income | 881M 27.69M 23.99M 22.64M 20.54M 38.53M 2.65B 38.81M 270M 104M 1.35B 104M 102M 4.28B | 928M 29.17M 25.28M 23.86M 21.64M 40.6M 2.8B 40.89M 285M 110M 1.42B 110M 107M 4.51B |
| Net Debt | -1.24B -39.11M -33.89M -31.98M -29.01M -54.42M -3.75B -54.82M -382M -147M -1.9B -147M -144M -6.05B | -1.44B -45.17M -39.14M -36.93M -33.51M -62.85M -4.33B -63.31M -441M -170M -2.2B -170M -166M -6.98B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | NT$55.90 | -0.18% | 108,454 |
| 26-09-11 | NT$56.00 | -0.53% | 183,746 |
| 26-09-10 | NT$56.30 | +0.18% | 126,593 |
| 26-09-09 | NT$56.20 | +0.36% | 219,725 |
| 26-09-08 | NT$56.00 | -0.36% | 223,193 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1720 Stock
Select your edition
All financial news and data tailored to specific country editions
